Matthews International Capital Management LLC Hutchmed (China) LTD Transaction History

Matthews International Capital Management LLC

$589 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 10, 2018	SELL	$28.87 - $41.13 $7.34 Million - $10.5 Million	-254,300 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$27.41 - $39.42 $529,013 - $760,806	-19,300 Reduced 7.05%	254,300 $10 Million
Q3 2017 Nov 13, 2017	BUY	$22.15 - $27.5 $500,589 - $621,500	22,600 Added 9.0%	273,600 $7.46 Million
Q2 2017 Aug 11, 2017	BUY	N/A	251,000	251,000 $5.85 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

8.25M

Call Options Held

3.8K

Put Options Held

2.4K

Schroder Investment Management Group London, X0

3.02M
Shares

$54.4 Million
0.06% of portfolio
Allianz Asset Management Gmb H Munich, 2M

1.5M
Shares

$27 Million
0.04% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.15M
Shares

$20.7 Million
0.33% of portfolio
Acadian Asset Management LLC Boston, MA

389K
Shares

$7 Million
0.02% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

358K
Shares

$6.44 Million
0.0% of portfolio

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account